2 ASX shares I can’t ignore: CSL and RMD
Rask Invest Research Team
March 1, 2024
The CSL Ltd (ASX:CSL) share price has increased 1.6% since
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
The CSL Ltd (ASX:CSL) share price has increased 1.6% since
The Resmed CDI (ASX:RMD) share price is lower 7.2% since
The CSL Ltd (ASX:CSL) share price is up 1.3% since
The Resmed CDI (ASX:RMD) share price is lower 9.3% since
The CSL Ltd (ASX:CSL) share price has increased 0.2% since
The Resmed CDI (ASX:RMD) share price is lower 8.8% since
The CSL Ltd (ASX:CSL) share price is up 0.7% since
The Resmed CDI (ASX:RMD) share price is lower 8.3% since
The CSL Ltd (ASX:CSL) share price has increased 8.3% since
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
